A 24-year-old woman from Wales in the United Kingdom became the first person in the UK to receive the Moderna vaccine today. England is expected to start using it in a few days. The report on the association between the AZ vaccine and thrombosis is also expected to be released later today.
The British Broadcasting Corporation (BBC) reported that the European Medicines Agency (EMA) expects to announce the latest assessment of adverse events in the AstraZeneca (AZ) vaccine at 3 pm British Summer Time this afternoon.
Many European countries have announced a suspension of the AZ vaccine due to the possible relationship between AZ vaccine and thrombosis. The British Medicines and Healthcare Products Administration (MHRA) stated in early April that 18.1 million people in the UK were vaccinated with AZ, and the government’s website received 30 notifications of thrombosis cases, of which 7 people were unfortunately killed.
The University of Oxford said yesterday that as regulatory authorities are assessing the link between the AZ vaccine and thrombosis, it has suspended small-scale trials in children and adolescents in the UK.
In the United Kingdom, from the first American pharmaceutical company Pfizer (Pfizer) and German biotech company BioNTech to jointly develop vaccines, to the AZ vaccine jointly developed by Oxford University, today began to use the third type. ) Production of vaccines. All three vaccines require two doses.
The Minister of Health Matt Hancock said that he is happy that the UK has started vaccination against Modena. He said: “The British government guarantees the number of vaccines for the country, and the vaccination plan shows that the country is working hard to prevent the epidemic.”
The Modena vaccine was tested in the United States across races and ages, and more than 30,000 people participated. The results showed that it had 94.1% protection.
The United Kingdom has ordered 17 million doses of Modena vaccine, which is enough to vaccinate 8.5 million people. The most ordered is the AZ vaccine, which is currently in doubt about blood clots, with as many as 100 million doses.
More than 31.6 million people in the UK have received the first dose of vaccine, of which 5.4 million have completed the second dose.